[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100634804":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":43,"responsibleParty":117,"collaborators":119,"id":126,"slug":127,"hasResults":128,"nctId":129,"briefTitle":130,"officialTitle":131,"acronym":132,"eligibilityCriteria":133,"healthyVolunteers":128,"sex":134,"minAge":135,"maxAge":26,"enrollmentInfo":136,"targetDuration":26,"studyType":139,"phases":140,"briefSummary":142,"conditions":143,"keywords":146,"overallStatus":154,"whyStopped":26,"lastUpdateSubmitDate":155,"lastUpdatePostDateStruct":156,"startDateStruct":159,"completionDateStruct":161,"leadSponsor":163,"locationsCount":164},{"fullName":5,"class":6},"Lindenhofgruppe AG","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Initial psycho-oncological contact","EXPERIMENTAL","Participants in the Intervention Arm will be contacted by a psycho-oncological counsellor. The study intervention is a 45 minutes psycho-oncological counselling and a 3 months follow-up contact.",[13],"Other: initial psycho-oncological contact",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard","ACTIVE_COMPARATOR","Participants in the Control Arm will receive actual standard of care psycho- oncological support according to local processes.",[19],"Other: Standard",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"OTHER","initial psycho-oncological contact","initial psycho-oncological contact and a 3 months follow-up contact",[9],null,{"type":22,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"actual standard of care psycho-oncological support according to local processes",[15],[31],{"name":32,"affiliation":33,"role":34},"Janine Antonov, PhD, eMBA","Forschungszentrum Lindenhofgruppe","STUDY_CHAIR",[36,40],{"name":32,"role":37,"phone":38,"phoneExt":26,"email":39},"CONTACT","+41 79 359 29 99","janine.antonov@lindenhofgruppe.ch",{"name":33,"role":37,"phone":41,"phoneExt":26,"email":42},"+41 31 366 36 66","forschungszentrum@lindenhofgruppe.ch",[44,63,78,87,102],{"facility":45,"status":26,"city":46,"state":26,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"St. Claraspital","Basel","4058","Switzerland","CH",{"type":51,"coordinates":52},"Point",[53,54],7.57327,47.55839,{"lat":54,"lon":53},[57,61],{"name":58,"role":37,"phone":59,"phoneExt":26,"email":60},"Arnoud Templeton, Prof. Dr. med.","+41 61 685 84 39","arnoud.templeton@claraspital.ch",{"name":58,"role":62,"phone":26,"phoneExt":26,"email":26},"PRINCIPAL_INVESTIGATOR",{"facility":64,"status":26,"city":65,"state":26,"zip":66,"country":48,"countryCode":49,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"University Hospital Insel Gruppe AG","Bern","3010",{"type":51,"coordinates":68},[69,70],7.44744,46.94809,{"lat":70,"lon":69},[73,77],{"name":74,"role":37,"phone":75,"phoneExt":26,"email":76},"Alexander Wünsch, Prof. Dr. phil.","+41 31 632 27 05","alexander.wuensch@insel.ch",{"name":74,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":79,"status":26,"city":65,"state":26,"zip":80,"country":48,"countryCode":49,"cosmosGeoPoint":81,"geoPoint":83,"contacts":84},"Lindenhofgruppe","3012",{"type":51,"coordinates":82},[69,70],{"lat":70,"lon":69},[85,86],{"name":32,"role":37,"phone":38,"phoneExt":26,"email":39},{"name":32,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":88,"status":26,"city":89,"state":26,"zip":90,"country":48,"countryCode":49,"cosmosGeoPoint":91,"geoPoint":95,"contacts":96},"See-Spital","Horgen","8810",{"type":51,"coordinates":92},[93,94],8.59778,47.25983,{"lat":94,"lon":93},[97,101],{"name":98,"role":37,"phone":99,"phoneExt":26,"email":100},"Michael Kiessling, Dr. med. Dr. rer. nat.","+41 44 728 17 40","michael.kiessling@see-spital.ch",{"name":98,"role":62,"phone":26,"phoneExt":26,"email":26},{"facility":103,"status":26,"city":104,"state":26,"zip":105,"country":48,"countryCode":49,"cosmosGeoPoint":106,"geoPoint":110,"contacts":111},"Klinik für Hämatologie und Onkologie Hirs landen Zürich AG","Zurich","8032",{"type":51,"coordinates":107},[108,109],8.55,47.36667,{"lat":109,"lon":108},[112,116],{"name":113,"role":37,"phone":114,"phoneExt":26,"email":115},"Karin Hohloch, PD Dr.","+ 41 44 387 37 92","karin.hohloch@kho.ch",{"name":113,"role":62,"phone":26,"phoneExt":26,"email":26},{"type":118,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[120,122,124],{"name":121,"class":22},"Insel Gruppe AG, University Hospital Bern",{"name":123,"class":22},"St. Claraspital AG",{"name":125,"class":22},"Klinik Hirslanden, Zurich","100634804","what-impact-does-an-initial-psycho-oncological-contact-have-on-people-with-cancer-100634804",false,"NCT07544446","What Impact Does an Initial Psycho-oncological Contact Have on People With Cancer?","The Impact of a Standardised Initial Contact by a Psycho-oncological Counsellor on Anxiety and Depression, Quality of Life and the Use of Psycho-oncological Support in Cancer Patients: A Patient-initiated Multicentre Randomised Controlled Study - the Psycho-oncological Initial Contact Study (PICS)","PICS","Inclusion Criteria:\n\n* Patients with an oncological disease diagnosed within the last 3 months with planned or ongoing systemic oncologic treatment (e.g. chemotherapy, immunotherapy, hormone therapy) or a planned or ongoing radiotherapy\n* Patient is ≥18 years of age and legally competent\n* Patients must have understood and signed the study information and the informed consent form\n* Patients are willing and able to complete scheduled follow-up evaluations \u002F questionnaires as described in the informed consent\n* No previous contact with psycho-oncological services\n\nExclusion Criteria:\n\n* Documented severe functional impairment according to the ECOG Performance Status (ECOG 3-4)\n* Patients receiving or planned to receive treatments associated with a severe risk of toxicity (e.g., CAR-T cell therapy, myeloablative therapy)\n* Insufficient language skills in German\n* Inability to give informed consent\n* Refusal to participate in the study, unsigned informed consent","ALL","18 Years",{"count":137,"type":138},148,"ESTIMATED","INTERVENTIONAL",[141],"NA","When diagnosed with cancer, patients or their relatives may, if they wish, on the recommendation of the treatment team and\u002For in cases of high stress, seek psycho-oncological support.\n\nThis study investigates whether an initial consultation with a psycho-oncological specialist reduces anxiety and depression, improves quality of life, and whether patients subsequently make greater use of support services.\n\nParticipants will be randomised, meaning they will be assigned to groups at random to ensure that the results are comparable. In the intervention group, participants will receive a detailed initial consultation with a psycho-oncology specialist and standard treatment. In the control group, participants receive standard treatment. To gather results, questionnaires are administered at regular intervals (at the start, after 3 and 6 months). The study lasts a total of 6 months.\n\nThe study was developed by patients. It is being conducted simultaneously at several hospitals.",[144,145],"Cancer","Psycho-Oncology",[147,145,148,149,150,151,152,153],"cancer","Adults","anxiety and depression","quality of life","distress thermometer","systemic oncologic treatment","radiotherapy","NOT_YET_RECRUITING","2026-04-15",{"date":157,"type":158},"2026-04-22","ACTUAL",{"date":160,"type":138},"2026-06-01",{"date":162,"type":138},"2028-12-31",{"name":5,"class":6},5]